Basic Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. May 7, 2016; 22(17): 4338-4344
Published online May 7, 2016. doi: 10.3748/wjg.v22.i17.4338
Table 3 Pharmacokinetics (median ± IQR) of plasma monoethylglycinexylidide (n = 14)
VariableF0 controlF2F3F4P value
(n = 2)(n = 3)(n = 7)(n = 2)
C10 min (ng/mL)252 ± 31197 ± 38199 ± 10572 ± 380.280
C30 min (ng/mL)327 ± 561268 ± 3751,2120 ± 312,373 ± 203,40.033
C60 min (ng/mL)274 ± 711258 ± 3361,293 ± 262,351 ± 373,40.020
Cmax (ng/mL)327 ± 56282 ± 332143 ± 10682 ± 220.069
tmax (min)30.0 ± 0.040.0 ± 20.030.0 ± 20.017.5 ± 5.00.120
t½max (min)141.3 ± 110.1151.1 ± 188.346.9 ± 50.274.9 ± 75.90.545
AUC (ng/mL·min)16644 ± 3139114421 ± 25151,26100 ± 22862,33970 ± 16703,40.016
Kmax (ng/mL/min)43.7 ± 7.238.1 ± 83.817.7 ± 22.86.6 ± 1.50.358